DOACs offer several advantages over traditional anticoagulants. They are administered orally, eliminating the need for injections, which can be particularly beneficial for cancer patients who may already be dealing with multiple treatments. Additionally, DOACs have fewer dietary restrictions and do not require routine monitoring of blood levels, unlike warfarin. This can significantly improve the quality of life for cancer patients.
